177 related articles for article (PubMed ID: 29781244)
21. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
Yu Z; Wen L; Shen X; Zhang H
Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
[TBL] [Abstract][Full Text] [Related]
22. The μ-opioid receptor gene polymorphism 118A>G weakens the pharmacological action of buprenorphine.
Imai H; Morita M; Morita H; Ohyama T; Tanaka S; Uchida S; Namiki N; Uemura N; Ohashi K
Int J Clin Pharmacol Ther; 2020 Nov; 58(11):626-633. PubMed ID: 32870152
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.
Smith AH; Jensen KP; Li J; Nunez Y; Farrer LA; Hakonarson H; Cook-Sather SD; Kranzler HR; Gelernter J
Mol Psychiatry; 2017 Mar; 22(3):346-352. PubMed ID: 28115739
[TBL] [Abstract][Full Text] [Related]
24. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
[TBL] [Abstract][Full Text] [Related]
25. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
Daher M; Costa FM; Neves FA
Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
[TBL] [Abstract][Full Text] [Related]
26. The Influence of OPRM1 A118G Polymorphism on the Dosage of Morphine in Patients with Advanced Liver Cancer.
Cheng H; Chu X; Yi S
J Coll Physicians Surg Pak; 2021 Nov; 31(11):1375-1377. PubMed ID: 34689504
[TBL] [Abstract][Full Text] [Related]
27. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
[TBL] [Abstract][Full Text] [Related]
28. Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences.
Muriel J; Escorial M; Margarit C; Barrachina J; Carvajal C; Morales D; Peiró AM
Acta Pharm; 2023 Jun; 73(2):227-241. PubMed ID: 37307374
[TBL] [Abstract][Full Text] [Related]
29. Neurobehavioral effects of neonatal opioid exposure in mice: Influence of the OPRM1 SNP.
Robinson SA; Jones AD; Brynildsen JK; Ehrlich ME; Blendy JA
Addict Biol; 2020 Sep; 25(5):e12806. PubMed ID: 31267641
[TBL] [Abstract][Full Text] [Related]
30. Sex Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back Pain.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Flor A; Morales D; Peiró AM
Clin J Pain; 2020 Jun; 36(6):420-429. PubMed ID: 32149782
[TBL] [Abstract][Full Text] [Related]
31. Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder.
Kaya-Akyüzlü D; Özkan-Kotiloğlu S; Bal C; Avcıoğlu G; Yalçın-Şahiner Ş; Şahiner İV
Environ Toxicol Pharmacol; 2022 Oct; 95():103979. PubMed ID: 36174909
[TBL] [Abstract][Full Text] [Related]
32. A review of the existing literature on buprenorphine pharmacogenomics.
Meaden CW; Mozeika A; Asri R; Santos CD
Pharmacogenomics J; 2021 Apr; 21(2):128-139. PubMed ID: 33154520
[TBL] [Abstract][Full Text] [Related]
33. A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.
Kapur S; Sharad S; Singh RA; Gupta AK
J Integr Neurosci; 2007 Dec; 6(4):511-22. PubMed ID: 18181266
[TBL] [Abstract][Full Text] [Related]
34. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
35. OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.
Hajj A; Halepian L; Osta NE; Chahine G; Kattan J; Rabbaa Khabbaz L
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28346387
[TBL] [Abstract][Full Text] [Related]
36. μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer.
Cieślińska A; Sienkiewicz-Szłapka E; Kostyra E; Fiedorowicz E; Snarska J; Wroński K; Tenderenda M; Jarmołowska B; Matysiewicz M
Tumour Biol; 2015 Jun; 36(6):4655-60. PubMed ID: 25618602
[TBL] [Abstract][Full Text] [Related]
37. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery.
Fukuda K; Hayashida M; Ide S; Saita N; Kokita Y; Kasai S; Nishizawa D; Ogai Y; Hasegawa J; Nagashima M; Tagami M; Komatsu H; Sora I; Koga H; Kaneko Y; Ikeda K
Pain; 2009 Dec; 147(1-3):194-201. PubMed ID: 19783098
[TBL] [Abstract][Full Text] [Related]
38. Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter.
Sandoval-Sierra JV; Salgado García FI; Brooks JH; Derefinko KJ; Mozhui K
Clin Epigenetics; 2020 Jun; 12(1):76. PubMed ID: 32493461
[TBL] [Abstract][Full Text] [Related]
39. Micro opioid receptor A118G polymorphism and post-operative pain: opioids' effects on heterozygous patients.
De Capraris A; Cinnella G; Marolla A; Salatto P; Da Lima S; Vetuschi P; Consoletti L; Gesualdo L; Dambrosio M
Int J Immunopathol Pharmacol; 2011; 24(4):993-1004. PubMed ID: 22230405
[TBL] [Abstract][Full Text] [Related]
40. Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment.
Tolami HF; Sharafshah A; Tolami LF; Keshavarz P
J Mol Neurosci; 2020 Apr; 70(4):504-513. PubMed ID: 31853823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
